July 30, 2020
July 30, 2020 —
Researchers at UC San Diego School of Medicine and Moores Cancer Center report that an investigational drug candidate called tipifarnib showed promise in treating key recurring mutation in head and neck cancers.
June 1, 2015
June 1, 2015 —
…Diego Health System have identified a previously unknown gene mutation that underlies this disorder.
January 2, 2023
January 2, 2023 —
In this scientific presentation, UC San Diego researchers describe using machine learning to train an artificial neural network to spot tiny mutations in genetic sequences better and faster than human eyes.
August 1, 2022
August 1, 2022 —
UC San Diego researchers report that individuals with two copies of a gene mutation show evidence of substantial iron buildup in regions of the brain, raising risk for movement disorders like Parkinson’s disease.
October 9, 2013
October 9, 2013 —
…California, San Diego School of Medicine, says a gene mutation that causes a rare but devastating neurological disorder known as Lesch-Nyhan syndrome appears to offer clues to the developmental and neuronal defects found in other, diverse neurological disorders like Alzheimer’s, Parkinson’s and Huntington’s diseases.
August 1, 2013
August 1, 2013 —
…San Diego School of Medicine have identified the gene mutation responsible for a particularly severe form of pontocerebellar hypoplasia, a currently incurable neurodegenerative disease affecting children. Based on results in cultured cells, they are hopeful that a nutritional supplement may one day be able to prevent or reverse the condition.
September 27, 2016
September 27, 2016 —
…testes in mice. The investigators also linked RHOX gene mutations to male infertility in humans.
October 12, 2016
October 12, 2016 —
…California San Diego School of Medicine have confirmed that mutation-caused dysfunction in a process cells use to transport molecules within the cell plays a previously suspected but underappreciated role in promoting the heritable form of Alzheimer’s disease (AD), but also one that might be remedied with existing therapeutic enzyme inhibitors.
January 22, 2024
January 22, 2024 —
Over 18 million people worldwide are annually diagnosed with cancer, with each case hiding many mutations in its genome. Understanding these mutations furthers cancer research, while also providing a deeper understanding to create possible cures, therapies and prevention strategies.
May 25, 2014
May 25, 2014 —
Researchers at the University of California, San Diego School of Medicine have identified a mutated gene common to adenosquamous carcinoma (ASC) tumors – the first known unique molecular signature for this rare, but particularly virulent, form of pancreatic cancer.